From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies
- PMID: 38243695
- PMCID: PMC10796252
- DOI: 10.1093/bib/bbad514
From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies
Erratum in
-
Correction to: From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies.Brief Bioinform. 2024 Jan 22;25(2):bbae100. doi: 10.1093/bib/bbae100. Brief Bioinform. 2024. PMID: 38446744 Free PMC article. No abstract available.
Abstract
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of muscle disorders including adult and juvenile dermatomyositis, polymyositis, immune-mediated necrotising myopathy and sporadic inclusion body myositis, all of which present with variable symptoms and disease progression. The identification of effective biomarkers for IIMs has been challenging due to the heterogeneity between IIMs and within IIM subgroups, but recent advances in machine learning (ML) techniques have shown promises in identifying novel biomarkers. This paper reviews recent studies on potential biomarkers for IIM and evaluates their clinical utility. We also explore how data analytic tools and ML algorithms have been used to identify biomarkers, highlighting their potential to advance our understanding and diagnosis of IIM and improve patient outcomes. Overall, ML techniques have great potential to revolutionize biomarker discovery in IIMs and lead to more effective diagnosis and treatment.
Keywords: biomarkers; idiopathic inflammatory myopathies; machine learning; myositis-specific autoantibodies.
© The Author(s) 2024. Published by Oxford University Press.
Figures





Similar articles
-
Idiopathic inflammatory myopathies.Neurol Clin. 2014 Aug;32(3):595-628, vii. doi: 10.1016/j.ncl.2014.04.007. Neurol Clin. 2014. PMID: 25037081 Free PMC article. Review.
-
Discovery of new biomarkers of idiopathic inflammatory myopathy.Clin Chim Acta. 2015 Apr 15;444:117-25. doi: 10.1016/j.cca.2015.02.007. Epub 2015 Feb 11. Clin Chim Acta. 2015. PMID: 25681646 Review.
-
Inflammatory muscle disease - An update.Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101484. doi: 10.1016/j.berh.2019.101484. Epub 2020 Feb 8. Best Pract Res Clin Rheumatol. 2020. PMID: 32046904 Review.
-
Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.Mayo Clin Proc. 2013 Jan;88(1):83-105. doi: 10.1016/j.mayocp.2012.10.017. Mayo Clin Proc. 2013. PMID: 23274022 Review.
-
Clinical features and diagnostic tools in idiopathic inflammatory myopathies.Crit Rev Clin Lab Sci. 2022 Jun;59(4):219-240. doi: 10.1080/10408363.2021.2000584. Epub 2021 Nov 12. Crit Rev Clin Lab Sci. 2022. PMID: 34767470 Review.
Cited by
-
Discovery of urinary biosignatures for tuberculosis and nontuberculous mycobacteria classification using metabolomics and machine learning.Sci Rep. 2024 Jul 3;14(1):15312. doi: 10.1038/s41598-024-66113-x. Sci Rep. 2024. PMID: 38961191 Free PMC article.
-
Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.Int J Mol Sci. 2024 Feb 27;25(5):2742. doi: 10.3390/ijms25052742. Int J Mol Sci. 2024. PMID: 38473988 Free PMC article. Review.
-
Artificial intelligence-enabled precision medicine for inflammatory skin diseases.ArXiv [Preprint]. 2025 May 14:arXiv:2505.09527v1. ArXiv. 2025. PMID: 40463698 Free PMC article. Preprint.
-
Balancing Clinical Applicability and Scientific Depth in ML Models for MDA5-DM Prognosis.Brief Bioinform. 2024 May 23;25(4):bbae295. doi: 10.1093/bib/bbae295. Brief Bioinform. 2024. PMID: 38949189 Free PMC article. No abstract available.
-
From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.Brief Bioinform. 2024 May 23;25(4):bbae303. doi: 10.1093/bib/bbae303. Brief Bioinform. 2024. PMID: 38920344 Free PMC article. No abstract available.
References
-
- Hočevar A, Rotar Z, Krosel M, et al. Performance of the 2017 European league against rheumatism/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice. Ann Rheum Dis 2018;77(12):e90. - PubMed
-
- Group F-NBW . Best (Biomarkers, Endpoints, and Other Tools) Resource. Silver Spring, Bethesda, Maryland: Food and Drug Administration (US) National Institutes of Health (US), 2016.
-
- Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57(5):664–78. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical